Ebola Emergency: WHO Declares Outbreak, DRC & Uganda at High Risk
WHO declares Ebola outbreak in DRC a global health emergency.
Top Summary
- What happened: WHO declared the Bundibugyo Ebola outbreak in DRC a Public Health Emergency of International Concern.
- Why it matters: The outbreak is spreading rapidly, with a high risk of further escalation, especially in bordering countries.
- What changes for people: Increased surveillance, potential travel restrictions, and heightened healthcare protocols in affected regions.
- Who is affected: Primarily the DRC and Uganda, with bordering countries at high risk; healthcare workers; and communities in Ituri and North Kivu provinces.
Ebola Outbreak Declared a Global Emergency
The World Health Organization (WHO) has declared the Ebola outbreak in the Democratic Republic of Congo (DRC) a Public Health Emergency of International Concern, effective May 17th.
The declaration followed consultations with the Health Ministers of DRC and Uganda, and notification from the Africa CDC.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the severity of the situation during a virtual ministerial briefing.
Rapid Spread and High-Risk Assessment
The outbreak is characterized by its rapid spread. To date, 101 confirmed cases and 10 confirmed deaths have been reported in the DRC.
However, the actual scale of the epidemic is believed to be much larger, with over 900 suspected cases and 220 suspected deaths.
WHO has upgraded the risk assessment at the national level from high to very high. The regional risk remains high, while the global risk is currently assessed as low.
Uganda's Response and Regional Impact
Uganda has reported five confirmed cases and one death.
President Museveni's decision to cancel the Martyrs’ Day commemoration, which typically attracts up to 2 million people, has been praised as a crucial measure to prevent further spread.
Countries bordering DRC are at especially high risk and should take immediate action to prepare for potential spillover.
Challenges and Response Efforts
The outbreak faces several challenges, including delayed detection and insecurity in affected regions. The provinces of Ituri and North Kivu are experiencing intensified fighting, leading to displacement and distrust of outside authorities.
Building trust within affected communities is a top priority.
WHO, in partnership with the Africa CDC, is establishing a continental Incident Management Support Team (IMST) and finalizing a multi-agency Strategic Preparedness and Response Plan, aligned with the national plans of both DRC and Uganda.
Medical Countermeasures and Clinical Trials
There are currently no approved vaccines or therapeutics for the Bundibugyo virus. WHO is prioritizing the evaluation of two monoclonal antibodies in clinical trials and is also recommending the evaluation of the antiviral obeldesivir as post-exposure prophylaxis for high-risk contacts.
This clinical trial is being developed jointly with Africa CDC and the Collaborative Open Research Consortium on filoviruses.
WHO is discussing potential candidate vaccines with partners in the development and manufacturing pipeline.
WHO's Commitment and Call to Action
WHO has released US$ 3.9 million from the Contingency Fund for Emergencies.
"We are facing an extremely serious and difficult outbreak. It will get worse before it gets better. But we know this virus, and we know how to stop it. We have stopped every previous Ebola outbreak, and we will stop this one too."
WHO is fully committed to working under the leadership of the Governments of DRC and Uganda, alongside Africa CDC and other partners, to bring the outbreak under control.
What to Watch Next
The Director-General of WHO will be traveling to DRC with Dr. Chikwe Ihekweazu to assess the situation firsthand and coordinate response efforts. Further updates on clinical trial results and vaccine development are expected in the coming weeks.